Macaulay, V. M., Middleton, M. R., Eckhardt, S. G., Rudin, C. M., Juergens, R. A., Gedrich, R., . . . Gadgeel, S. M. (2016). Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors. Clinical cancer research, 22(12), 2897. https://doi.org/10.1158/1078-0432.CCR-15-2218
Citace podle Chicago (17th ed.)Macaulay, Valentine M., et al. "Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors." Clinical Cancer Research 22, no. 12 (2016): 2897. https://doi.org/10.1158/1078-0432.CCR-15-2218.
Citace podle MLA (9th ed.)Macaulay, Valentine M., et al. "Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors." Clinical Cancer Research, vol. 22, no. 12, 2016, p. 2897, https://doi.org/10.1158/1078-0432.CCR-15-2218.